Deep Dive: Deep Dive Into Veterinary CBD Research
On this episode of Deep Dive, Stephen Cital, RVT with a background in cannabis research, provides insight on the hot topic of CBD in the veterinary world. He discusses what fueled his passion for veterinary CBD research, how veterinarians should go about discussing the CBD topic with clients, and beyond. Plus, he previews a textbook he coedited titled, “Cannabis Therapy in Veterinary Medicine.”
Inside the Practice: Inside Mandel Global Leadership and Learning Institute
Dr. Brian Bolwell discusses his new role as Chair, Physician Leadership and Development within the Mandel Global Leadership and Learning Institute at Cleveland Clinic, where he will work to advance professional staff leadership across the enterprise.
Behind the Science: Behind ASCO Findings
The 2021 American Society of Clinical Oncology Annual Meeting (ASCO 2021) continues to hold its place as the most impactful medical meeting for advancements in the field of cancer treatment, with pivotal presentations across a wide range of different tumor types shaking up the standard of care each year.
Inside the Practice: Inside a Next Generation Dialysis Device
Dr. Brandon Repko talks about how the WavelinQ EndoAVF system gives physicians a minimally invasive option for creating an AV fistula for patients who need hemodialysis to survive. Repko is part of a postmarket study called CONNECT-AV following patients treated with the device for an additional 24 months.
Inside the Practice: Inside Cognoa’s Canvas Dx
Dr. Sharief Taraman explains Cognoa’s Canvas Dx, a first-of-its-kind autism diagnostic tool, being authorized for marketing by the US Food and Drug Administration for the physician-aided diagnosis of autism spectrum disorder (ASD) in a primary care setting.
Behind the Science: Telemedicine’s Paradigm Shift in Stroke Care
Telemedicine’s Paradigm Shift and Needs in Neurology Research NeurologyLive inquired with a trio of stroke specialists of varying clinical expertise to find out their thoughts on and experiences with telemedicine in the care of patients with stroke, particularly in light of the massive shift toward this method of care amid the COVID-19 pandemic; and inquired with another pair of stroke physicians to find out what lingering research needs are plaguing the field of stroke care."
Behind the Science: Behind Geronimo Animal Rescue Team
Stacey Thomas and cofounder of the Geronimo Animal Rescue Team (GART) Kiaya Jackson discuss a wide variety of topics including, the history of Jackson’s reservation, human-animal bond between Jackson’s community and pets, and what the San Carlos Dog House Project is.
Inside the Practice: Inside Mismatched Unrelated Donor Transplantation
Dr. Jeffery Auletta discusses recently published research regarding mismatched unrelated donors stem cell transplant in patients with acute leukemias and myelodysplastic syndrome. The findings indicates that HLA-matched unrelated donors may offer better outcomes for patient’s vs half-matched related donors.
Deep Dive: Deep Dive Into Psychedelic Compounds to Treat Obesity
Pharmacy Times interviewed Dr. Clive Ward Able, the president of Clintell and a trained pharmacist and physician who has worked in the pharmacy industry for over 30 years. During this discussion, Dr. Ward Able addresses his research investigating the use of psychedelic compounds to treat obesity, as well as optimize human health.
Inside the Practice: Inside EyeLib
Dr. Michael Assouline joins to discuss new technology for screening for and diagnosing ophthalmic conditions. EyeLib is described as an AI-device that “allows for rapid fully automated advanced and comprehensive ophthalmological diagnoses and consequent referrals to the appropriate specialists.” Essentially, the idea is that all the medical devices used at the beginning of a check-up are combined into one streamlined machine.
Inside the Practice: Inside Top Derm
A recently launched application, Top Derm, developed by medical video game company Level Ex, made for dermatologists. The free-to-play mobile app presents users with exercises and challenges on a variety of dermatologic concepts that are designed to encourage learning and strengthen recall. Level Ex collaborated with over 140 dermatologists, including Dr. Peter Lio, to design the game. Dr. Lio speaks about the application’s design, how the game works, its value for dermatologists of all skill levels, and its future as a resource for clinicians.
Deep Dive: Deep Dive Into Aducanumab’s Appropriate Use Criteria
Dr. Alireza Atri, the director of the Banner Sun Health Research Institute in Sun City, AZ, joined Deep Dive from the floor of the 2021 Alzheimer’s Association International Conference to discuss the recently published and presented Appropriate Use Criteria for aducanumab, or Aduhelm, Biogen’s newly approved anti-amyloid agent for the treatment of Alzheimer’s disease.
Deep Dive: Deep Dive Into Bevacizumab Biosimilars for Eye Conditions
As use of reference bevacizumab (Avastin) for the treatment of macular degeneration has increased over the past decade, payers have begun to recommend bevacizumab biosimilars for the same indication. However, some institutions, including the American Academy of Ophthalmology, say that there needs to be more evidence for the use of these biosimilars for macular degeneration and that recommending them for use is premature.
Inside the Practice: Inside ABC Kids Dental Group's Robot for Children
Robin the Robot from Expper Technologies is an interactive companion designed to help children feel comfortable in hospitals, dental practices, and other healthcare settings. ABC Kids Dental Group in Los Angeles was the first practice in the area to add Robin to the practice, and the impact has been amazing.
Inside the Practice: Inside Advancing Inclusive Research Site Alliance
Quita Highsmith and Dr. Monica Baskin discuss the Advancing Inclusive Research Site Alliance, a new initiative by Genentech to include more diverse populations in clinical trials. Highsmith and Baskin touch on why it’s important to have started this alliance and how they hope to see the program grow to include other cancer centers.
Behind the Science: Behind Fecal Microbiota Transplantation
Five experts in gastroenterology and infectious disease discuss what they think the future is for fecal microbiota transplantation (FMT) in treating recurrent C. difficile infection, which is linked with high mortality. The availability of FMT has been limited since the COVID-19 pandemic began, and more standardized preparations are being explored.
Deep Dive: Deep Dive Into the RPH-104 Molecule
Yan Lavrovsky, MD, PhD discusses the RPH-104 Molecule, a biological project that is currently being developed to treat a variety of inflammatory diseases, metabolic diseases, recurrent fever, joint lesions, and rashes. Dr. Lavrovsky discusses why the FDA approval of the molecule is so groundbreaking, future research, and what first sparked his team’s interest in researching and developing the RPH-104 molecule.
Inside the Practice: Inside New Breast Cancer Tech
For patients with breast cancer whose disease has spread to the axillary lymph nodes, the use of a new reflector device technology in the early neoadjuvant chemotherapy setting can help to more accurately pinpoint cancerous nodes for resection, and potentially improve outcomes. Leslie L. Montgomery, MD, and Tara M. Balija, MD, discuss the benefits of a novel reflector device in patients with breast cancer, its efficacy in identifying clipped axillary lymph nodes, and the potential future use of this device in other cancer types.
Deep Dive: Deep Dive Into Possibilities in Cancer Care
Previewing New Jersey’s first free-standing cancer center, Dr Steven Libutti, director of the Rutgers Cancer Institute of New Jersey, speaks with The American Journal of Managed Care on how the upcoming Jack and Sheryl Morris Cancer Center will open possibilities in cancer care that were otherwise unavailable in the state. Dr Libutti discusses the capabilities in oncology care and clinical trial research that will be provided at the Rutgers-affiliated center, and its implications for a state marked by one of the highest cancer rates nationwide.
Deep Dive: Deep Dive Into Digital Twin Imaging Platform
Utilizing its innovative whole-body scanner, Q Bio develops breakthrough technology to measure changes in the human body like never before. Q Bio unveiled the first clinical "digital twin" platform, Q Bio Gemini, to capture and monitor comprehensive baseline patient health in a scalable virtual model. In this interview, Q Bio CEO Jeff Kaditz discusses the company’s leading technology that is driving this innovation.
Behind the Science: Behind New Drugs for Obesity
The epidemic of chronic obesity in the US is driving increases in a wide range of other dangerous and deadly chronic illnesses. Prevention and management of overweight and obesity are rightly the concern of primary care but there are myriad challenges for both patients and physicians to arresting or reversing the process of unhealthy weight gain. There now are several physiologic that act on the physiologic underpinnings of obesity and may significantly enhance the success of patients’ efforts at behavioral change (eg, diet and physical activity).
Inside the Practice: Inside Brio Dental's Holistic Approach to Dental Care
Holistic Dentistry can be a controversial topic among dental professionals, but at Brio Dental in Portland, Oregon, Karaneh Jahan, DMD, looks to provide care for the entire patient with a focus on services and products that reduce the use of metals and avoid known toxins such as mercury. Dr Jahan shares her personal story of pursuing a holistic approach to her own health challenges, and explains she incorporates those same principles into the care she provides to her patients.
Inside the Practice: Inside Creating Digital Tools to Improve Disease Management
Avoiding clinical inertia and achieving optimal levels of prescribing for guideline-directed medical therapies is a problem that spans across almost all specialties in medicine. In cardiology, clinicians point to gaps in prescribing of guideline-directed therapies as a treatment gap leading to negative outcomes for some patients. In this edition of Inside the Practice, Dr. Stephen Greene discusses the process of creating a digital dashboard for increasing prescribing of guideline-directed therapies that was recently rolled out within the Duke Medicine health systems.
Deep Dive: Deep Dive Into Drug Development Through Pathway Approach
The COVID pandemic is driving interest in the importance of the immune system to human health, and platform technologies to preventing and treating disease. There are roughly 60 million patients in western society dealing with immune mediated diseases. Tackling drug development through a pathway approach opens the potential to treat multiple diseases with one therapy. New ongoing research by Janssen Immunology continues to validate their “pipeline in a pathway” model to treating immune mediated diseases in multiple therapeutic areas including psoriasis, psoriatic arthritis, Crohn’s, ulcerative colitis and more.
Behind the Science: Behind Microbiota Treatments
A panel of experts discuss how live microbiota treatments currently in development could transform care for CDI. One theme is that antibiotic use increases the risk of infections, meaning some non-antibiotic options need to emerge. The treatments are based off the success of fecal microbiota transplantation for C difficile.
Inside the Practice: Inside Assisted and Robotic Surgery
Greg Marchand, MD, FACS, FACOG, FICS, Director of the Marchand Institute for Minimally Invasive Surgery. He talks about robotic and assisted laparoscopic surgery and shows how his simulators of the two different machines work. He also explains the many benefits to assisted or robotic surgery.
Inside the Practice: Inside Prescription Kiosks
Asteres® chairman and BioIQ CEO, Sean Slovenski joined Inside the Practice to discuss 24/7 automated pharmacy pickup. ScriptCenter allows your pharmacy staff to maintain control of filling and checking prescriptions, while ScriptCenter takes care of the secure storage, tracking, pickup, and payment of your pharmacist-filled prescriptions. Asteres® develops ScriptCenter kiosks and lockers for secure and safe pickup of prescriptions and healthcare products.
Inside the Practice: Inside Transperineal Prostate Biopsies
Dr. Matthew Allaway, DO, spoke with CancerNetwork about a prostate cancer biopsy technique that uses the transperineal approach to better detect cancer in harder to reach areas of the prostate. Along with this, Allaway touched on the American Cancer Society’s annual report, “Cancer Facts & Figures 2022” and detailed the important findings from a companion study to that information.
Inside the Practice: Inside Global Society of Rare Genitourinary Tumors
The Global Society of Rare Genitourinary Tumors launched during the pandemic, hoping to give a voice to those who have or treat rare cancers in this space. In a recent interview, Philippe E. Spiess, MD, MS, FRCSC, FACS, and Andrea Necchi, MD, share how they aim to develop an environment that emphasizes education, patient advocacy, and clinical research for this subspecialty—one that has historically failed to receive the spotlight as much as other, more common cancers. Spiess and Necchi serve as President and Vice President of this organization.
Behind the Science: Behind New RNA Platform for Detecting Pregnancy Complications
On this week’s episode of Behind the Science, Contemporary OBGYN sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Inside the Practice: Inside A Cancer Symptom Management App
Ovarian cancer can bring an onslaught of more than a dozen symptoms, as well as lingering anxiety and other difficulties for patients and their caregivers. Heidi Donovan, a professor at the University of Pittsburgh School of Nursing is working with app developer Haomin (Leon) Hu to change that. Their app, which is currently in the early stages of development and is slated to launch next year, will help patients and their caregivers track and manage symptoms, leading to a better feeling of control over the disease.
Wellbeing Checkup: Cutting-Edge Science Improves Patient Outcomes
Burnout seemed to be at an all-time high for health care providers during the COVID-19 pandemic. When it comes to treating patients with blood cancer, their immunocompromised status put even more stress on doctors, as they now had an added layer of worry and concern for the people they were treating. However, when major advances enter the space – such as the recent FDA approval of cilta-cel for pretreated, relapsed/refractory multiple myeloma – clinicians can once again feel empowered and exciting, explained Dr. Sundar Jagannath, MBBS, professor of Medicine and director of the Multiple Myeloma Center of Excellence at the Tisch Cancer Institute in New York.
Deep Dive: Deep Dive Into the Burn Reversal Method
James Beckman, MD, is the creator of a topical application that stops the progression of a first or second degree burn and reverse the symptoms already present as soon as possible after the burn. We discuss the science behind this burn reversal method, the complexities of working with burned skin, and what needs to be considered when working with a burned patient.
After Hours: Biosimilar Whiskey
As high-end whisky can take decades to develop and total to thousands of dollars per bottle, a novel process created by Sarfaraz Niazi, adjunct professor of biopharmaceutical sciences and advisory board member for the Center for Biosimilars®, seeks to circumvent both time and cost by replicating the biosimilar approach to therapeutic drugs to that of whisky. Dr. Niazi speaks with The American Journal of Managed Care® on the distillation process, how the biobetter whiskies compared with their reference products, and future considerations for the alcohol industry.
Inside the Practice: Inside Cleveland Clinic’s Virtual Reality Therapy for Parkinson's Disease
Dr. Jay Alberts, the vice-chair for innovations at Cleveland Clinic’s Neurological Institute and the Bell Family Endowed Chair of the Department of Biomedical Engineering, took NeurologyLive inside Cleveland Clinic to explore the institution’s use of virtual reality in the treatment and care of its patients with Parkinson disease.
Deep Dive: Deep Dive Into the GoutSMART App
Philip Riches, PhD, discusses his recent study, “Evaluation of supported self-management in gout (GoutSMART): a randomised controlled feasibility trial.” Results revealed improved urate targets in patients receiving supported self-management when compared with usual care.
Inside the Practice: Inside the DIEP Flap Procedure
The Allegheny Health Network breast reconstruction surgery team are, by their count, the second team in the nation to conduct regular practice with a key innovation: a robot-assisted deep inferior epigastric artery perforator (DIEP) flap procedure—a minimally invasive technique at the forefront of advancement for cancer-related reconstruction surgery. The interview features Dr. Moreira and Dr. Murariu explaining the intricacies of the procedure, keys to defining patient eligibility, and future utility of robot-assisted reconstruction surgery.
Deep Dive: Deep Dive Into Epstein-Barr Virus as a Cause of Multiple Sclerosis
Dr. Bridget A. Bagert sat down with NeurologyLive to discuss a hot topic of clinical concern in multiple sclerosis: Epstein-Barr virus. After 2 decades of research suggesting a link between EBV and MS, the findings of a recently published paper provided the most robust dataset to date, with analyses suggesting there may be a causal link between EBV infection and MS disease onset. Bagert, an expert in the field of MS who has focused on this link in her clinical research, offered her perspective on the findings the what is known to this point.